Characteristic | Solid tumour N = 19 | Haematological malignancy N = 28 | Combined N = 47 |
---|---|---|---|
Sex | |||
 Male | 9 | 18 | 27 |
 Female | 10 | 10 | 20 |
Median age (range), years | 59.2 (39.4–70.8) | 49.0 (21.7–79.4) | 53.1 (21.7–79.4) |
Median no. of prior lines of systemic therapy (range) | 2 (0–8) | 4 (1–10) | 3 (0–10) |
ECOG performance status | |||
 0 | 7 | 10 | 17 |
 1 | 12 | 18 | 30 |
Histology | Colorectal 4 | cHL 15 | Â |
Lung 4 | DLBCL 3 | ||
Upper GI 3 | AITL 4 | ||
Cervix 2 | PTCLNOS 2 | ||
Endometrial 1 | Indolent B-cell NHL 3 | ||
Breast 1 | GZL 1 | ||
Peritoneal 1 | Â | ||
Neuroendocrine 1 | |||
Head and neck SCC 1 | |||
Meningioma 1 | |||
Stage | |||
 III | 0 | 4 | N/A |
 III or IIIS | 2 | 6 | |
 IV | 17 | 18 | |
Baseline HR23B status (IHC) | |||
 Positive (6–7) | 15 | 17 | 32 |
 Negative (0–5) | 2 | 9 | 11 |
 Not available | 2 | 2 | 4 |